Diagnosis and Quantitation of Fibrosis

Gastroenterology

Volumn 134, Issue 6, 2008, Pages 1670-1681

  Manning, Diarmuid S ^a   Afdhal, Nezam H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CYTOKINE; LAMININ; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; BLOOD ANALYSIS; DIAGNOSTIC TEST; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; LIVER BIOPSY; LIVER FIBROSIS; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS;

EID: 42949130108     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.03.001     Document Type: Article

References (138)

1. W. Abdi J.C. Millan E. Mezey Sampling variability on percutaneous liver biopsy Arch Intern Med 139 1979 667 669
2. A. Regev M. Berho L.J. Jeffers Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2002 2614 2618
3. F. Imbert-Bismut V. Ratziu L. Pieroni Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 357 2001 1069 1075
4. T. Poynard F. Imbert-Bismut M. Munteanu Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C Comp Hepatol 3 2004 8
5. W.P. Harbin N.J. Robert J.T. Ferrucci Jr Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis Radiology 135 1980 273 283
6. M. Ziol A. Handra-Luca A. Kettaneh Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Hepatology 41 2005 48 54
7. C. Verveer R.J. de Knegt Noninvasive measurement of liver fibrosis: application of the FibroScan in hepatology Scand J Gastroenterol Suppl 2006 85 88
8. L. Huwart F. Peeters R. Sinkus Liver fibrosis: non-invasive assessment with MR elastography NMR Biomed 19 2006 173 179
9. G. Menghini One-second needle biopsy of the liver Gastroenterology 35 1958 190 199
10. F. Froehlich O. Lamy M. Fried Practice and complications of liver biopsy Results of a nationwide survey in Switzerland Dig Dis Sci 38 1993 1480 1484
11. K.D. Lindor C. Bru R.A. Jorgensen The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy Hepatology 23 1996 1079 1083
12. J. Perrault D.B. McGill B.J. Ott Liver biopsy: complications in 1000 inpatients and outpatients Gastroenterology 74 1978 103 106
13. P. Thampanitchawong T. Piratvisuth Liver biopsy: complications and risk factors World J Gastroenterol 5 1999 301 304
14. B. Terjung I. Lemnitzer F.L. Dumoulin Bleeding complications after percutaneous liver biopsy An analysis of risk factors Digestion 67 2003 138 145
15. J. Poniachik D.E. Bernstein K.R. Reddy The role of laparoscopy in the diagnosis of cirrhosis Gastrointest Endosc 43 1996 568 571
16. L. Pagliaro F. Rinaldi A. Craxi Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis A prospective, randomized trial Dig Dis Sci 28 1983 39 43
17. B. Maharaj R.J. Maharaj W.P. Leary Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver Lancet 1 1986 523 525
18. P. Schlichting B. Holund H. Poulsen Liver biopsy in chronic aggressive hepatitis Diagnostic reproducibility in relation to size of specimen Scand J Gastroenterol 18 1983 27 32
19. B. Holund H. Poulsen P. Schlichting Reproducibility of liver biopsy diagnosis in relation to the size of the specimen Scand J Gastroenterol 15 1980 329 335
20. P. Bedossa D. Dargere V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457
21. T. Poynard M. Munteanu F. Imbert-Bismut Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C Clin Chem 50 2004 1344 1355
22. M. Colombo E. Del Ninno R. de Franchis Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis Gastroenterology 95 1988 487 489
23. L. Vargas-Tank V. Martinez M.I. Jiron Tru-cut and Menghini needles: different yield in the histological diagnosis of liver disease Liver 5 1985 178 181
24. F. Oberti E. Valsesia C. Pilette Noninvasive diagnosis of hepatic fibrosis or cirrhosis Gastroenterology 113 1997 1609 1616
25. P. Bedossa T. Poynard S. Naveau Observer variation in assessment of liver biopsies of alcoholic patients Alcohol Clin Exp Res 12 1988 173 178
26. J. Westin L.M. Lagging R. Wejstal Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection Liver 19 1999 183 187
27. P. Bedossa P. Bioulac-Sage P. Callard Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C The French METAVIR Cooperative Study Group Hepatology 20 1994 15 20
28. C. Pilette M.C. Rousselet P. Bedossa Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores Comparison with serum markers J Hepatol 28 1998 439 446
29. R.D. Goldin J.G. Goldin A.D. Burt Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis J Hepatol 25 1996 649 654
30. M.J. O'Brien N.M. Keating S. Elderiny An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C Am J Clin Pathol 114 2000 712 718
31. A.M. Zaitoun H. Al Mardini S. Awad Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C J Clin Pathol 54 2001 461 465
32. Z.D. Goodman R.L. Becker Jr P.J. Pockros Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis Hepatology 45 2007 886 894
33. J. Parkes I.N. Guha P. Roderick Performance of serum marker panels for liver fibrosis in chronic hepatitis C J Hepatol 44 2006 462 474
34. S.L. Friedman Liver fibrosis—from bench to bedside J Hepatol 38 Suppl 1 2003 S38 S53
35. N.H. Afdhal D. Nunes Evaluation of liver fibrosis: a concise review Am J Gastroenterol 99 2004 1160 1174
36. A. Hayasaka D. Schuppan K. Ohnishi Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease J Hepatol 10 1990 17 22
37. L. Castera D.J. Hartmann F. Chapel Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis J Hepatol 32 2000 412 418
38. A. Kasahara N. Hayashi K. Mochizuki Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C Relationship to interferon response J Hepatol 26 1997 574 583
39. J.G. McHutchison L.M. Blatt M. de Medina Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology Consensus Interferon Study Group J Gastroenterol Hepatol 15 2000 945 951
40. Y. Murawaki Y. Ikuta M. Koda Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology Hepatology 20 1994 780 787
41. J.C. Trinchet Clinical use of serum markers of fibrosis in chronic hepatitis J Hepatol 22 1995 89 95
42. D. Schuppan M.C. Cantaluppi J. Becker Undulin, an extracellular matrix glycoprotein associated with collagen fibrils J Biol Chem 265 1990 8823 8832
43. X. Forns S. Ampurdanes J.M. Llovet Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 2002 986 992
44. M. Yamauchi Y. Mizuhara Y. Maezawa Serum tenascin levels in chronic liver disease Liver 14 1994 148 153
45. D. Thabut M. Simon R.P. Myers Noninvasive prediction of fibrosis in patients with chronic hepatitis C Hepatology 37 2003 1220 1221
46. C.T. Wai J.K. Greenson R.J. Fontana A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
47. N. Assy G.Y. Minuk Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults Am J Gastroenterol 95 2000 1545 1550
48. F.H. Anderson L. Zeng N.R. Rock An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C Hepatol Res 18 2000 63 71
49. G.J. Park B.P. Lin M.C. Ngu Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol 15 2000 386 390
50. S.G. Sheth S.L. Flamm F.D. Gordon AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection Am J Gastroenterol 93 1998 44 48
51. T.F. Imperiale A.T. Said O.W. Cummings Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C Am J Gastroenterol 95 2000 2328 2332
52. S.W. Schalm The diagnosis of cirrhosis: clinical relevance and methodology J Hepatol 27 1997 1118 1119
53. T. Kawasaki A. Takeshita K. Souda Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis Am J Gastroenterol 94 1999 1918 1922
54. R.H. Aster Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia J Clin Invest 45 1966 645 657
55. Y. Kamimoto S. Horiuchi S. Tanase Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells Hepatology 5 1985 367 375
56. L. Castera J. Vergniol J. Foucher Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
57. T.B. Kelleher S.H. Mehta R. Bhaskar Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index J Hepatol 43 2005 78 84
58. S. Islam L. Antonsson J. Westin Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers Scand J Gastroenterol 40 2005 867 872
59. C. Lackner G. Struber B. Liegl Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C Hepatology 41 2005 1376 1382
60. L.L. Schiavon J.L. Schiavon R.J. Filho Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection Hepatology 46 2007 307 314
61. C.S. Lieber D.G. Weiss T.R. Morgan Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis Am J Gastroenterol 101 2006 1500 1508
62. A.A. Shaheen R.P. Myers Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review Hepatology 46 2007 912 921
63. T. Poynard A. Aubert P. Bedossa A simple biological index for detection of alcoholic liver disease in drinkers Gastroenterology 100 1991 1397 1402
64. J.P. Teare D. Sherman S.M. Greenfield Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis Lancet 342 1993 895 898
65. R.P. Myers Y. Benhamou F. Imbert-Bismut Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients Aids 17 2003 721 725
66. R.P. Myers M. De Torres F. Imbert-Bismut Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index Dig Dis Sci 48 2003 146 153
67. E. Rossi L. Adams A. Prins Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients Clin Chem 49 2003 450 454
68. T. Poynard R. Morra P. Halfon Meta-analyses of Fibrotest diagnostic value in chronic liver disease BMC Gastroenterol 7 2007 40
69. G. Sebastiani A. Vario M. Guido Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C J Hepatol 44 2006 686 693
70. P. Halfon F. Imbert-Bismut D. Messous A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease Comp Hepatol 1 2002 3
71. T. Poynard F. Imbert-Bismut V. Ratziu Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial J Viral Hepat 9 2002 128 133
72. T. Poynard J. McHutchison M. Manns Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin Hepatology 38 2003 481 492
73. P. Halfon M. Bourliere R. Deydier Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the Fibropaca study Am J Gastroenterol 101 2006 547 555
74. M. Koda Y. Matunaga M. Kawakami FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C Hepatology 45 2007 297 306
75. L.A. Adams M. Bulsara E. Rossi Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection Clin Chem 51 2005 1867 1873
76. A. Vallet-Pichard V. Mallet B. Nalpas FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection Comparison with liver biopsy and fibrotest Hepatology 46 2007 32 36
77. R.K. Sterling E. Lissen N. Clumeck Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection Hepatology 43 2006 1317 1325
78. P. Angulo J.M. Hui G. Marchesini The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 2007 846 854
79. T.M.M. Poynard F. Charlotte V. Ratziu Direct comparison of two non invasive biomarkers for the diagnosis of advanced fibrosis in patients with non alcoholic fatty liver disease (NAFLD): NAFLD score and FibroTest Hepatology 46 2007 1 947
80. A. Pohl C. Behling D. Oliver Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection Am J Gastroenterol 96 2001 3142 3146
81. P. Angulo J.C. Keach K.P. Batts Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1999 1356 1362
82. C.T. McGary R.H. Raja P.H. Weigel Endocytosis of hyaluronic acid by rat liver endothelial cells Evidence for receptor recycling Biochem J 257 1989 875 884
83. J. Guechot A. Laudat A. Loria Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis Clin Chem 42 1996 558 563
84. Y. Murawaki Y. Ikuta K. Okamoto Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C J Gastroenterol 36 2001 399 406
85. A. Pares R. Deulofeu A. Gimenez Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis Hepatology 24 1996 1399 1403
86. Y. Idobe Y. Murawaki Y. Ikuta Post-prandial serum hyaluronan concentration in patients with chronic liver disease Intern Med 37 1998 568 575
87. G. Montalto M. Soresi F. Aragona Procollagen III and laminin in chronic viral hepatopathies Presse Med 25 1996 59 62
88. J.C. Trinchet D.J. Hartmann D. Pateron Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis Relationship to liver histology and conventional liver tests J Hepatol 12 1991 139 144
89. T. Nouchi T.M. Worner S. Sato Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease Alcohol Clin Exp Res 11 1987 287 291
90. O. Niemela J. Risteli J.E. Blake Markers of fibrogenesis and basement membrane formation in alcoholic liver disease Relation to severity, presence of hepatitis, and alcohol intake Gastroenterology 98 1990 1612 1619
91. E. Giannini S. Caglieris P. Ceppa Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C Eur J Gastroenterol Hepatol 13 2001 137 141
92. G.B. Gabrielli F. Capra M. Casaril Serum laminin and type III procollagen in chronic hepatitis C Diagnostic value in the assessment of disease activity and fibrosis Clin Chim Acta 265 1997 21 31
93. P.D. Maurice A.J. Maddox C.A. Green Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen Br J Dermatol 152 2005 451 458
94. S. Khan D. Subedi M.M. Chowdhury Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis Postgrad Med J 82 2006 353 354
95. R.J. Chalmers B. Kirby A. Smith Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis Br J Dermatol 152 2005 444 450
96. E. Hahn G. Wick D. Pencev Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin Gut 21 1980 63 71
97. D.K. George G.A. Ramm N.I. Walker Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis J Hepatol 31 1999 47 52
98. T. Ueno S. Inuzuka T. Torimura Significance of serum type-IV collagen levels in various liver diseases Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen Scand J Gastroenterol 27 1992 513 520
99. S. Matsumoto K. Yamamoto T. Nagano Immunohistochemical study on phenotypical changes of hepatocytes in liver disease with reference to extracellular matrix composition Liver 19 1999 32 38
100. K.M. Walsh A. Fletcher R.N. MacSween Basement membrane peptides as markers of liver disease in chronic hepatitis C J Hepatol 32 2000 325 330
101. M. Misaki T. Shima Y. Yano Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease Clin Chem 36 1990 522 524
102. R.C. Benyon M.J. Arthur Extracellular matrix degradation and the role of hepatic stellate cells Semin Liver Dis 21 2001 373 384
103. M.J. Arthur Fibrogenesis II Metalloproteinases and their inhibitors in liver fibrosis Am J Physiol Gastrointest Liver Physiol 279 2000 G245 G249
104. P. Fabris F. Marranconi L. Bozzola Fibrogenesis serum markers in patients with chronic hepatitis C treated with α-IFN J Gastroenterol 34 1999 345 350
105. K.M. Walsh P. Timms S. Campbell Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis Dig Dis Sci 44 1999 624 630
106. K.H. Boeker C.I. Haberkorn D. Michels Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C Clin Chim Acta 316 2002 71 81
107. Y. Murawaki Y. Ikuta K. Okamoto Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease J Hepatol 31 1999 474 481
108. A. Hayasaka N. Suzuki N. Fujimoto Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma Hepatology 24 1996 1058 1062
109. R.C. Benyon J.P. Iredale S. Goddard Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver Gastroenterology 110 1996 821 831
110. J.P. Iredale S. Goddard G. Murphy Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes Clin Sci (Lond) 89 1995 75 81
111. M. Larrousse M. Laguno M. Segarra Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients J Acquir Immune Defic Syndr 46 2007 304 311
112. J.S. Johansen P. Christoffersen S. Moller Serum YKL-40 is increased in patients with hepatic fibrosis J Hepatol 32 2000 911 920
113. C. Nojgaard J.S. Johansen E. Christensen Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease J Hepatol 39 2003 179 186
114. M. Zheng W.M. Cai J.K. Zhao Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value Acta Trop 96 2005 148 152
115. D.R. Nelson R.P. Gonzalez-Peralta K. Qian Transforming growth factor-β 1 in chronic hepatitis C J Viral Hepat 4 1997 29 35
116. S. Kanzler M. Baumann P. Schirmacher Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-β J Viral Hepat 8 2001 430 437
117. C.J. McClain D.A. Cohen Increased tumor necrosis factor production by monocytes in alcoholic hepatitis Hepatology 9 1989 349 351
118. Y. Ikura H. Morimoto M. Ogami Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease J Gastroenterol 32 1997 496 501
119. T. Shiraishi S. Morimoto E. Koh Increased release of platelet-derived growth factor from platelets in chronic liver disease Eur J Clin Chem Clin Biochem 32 1994 5 9
120. K. Patel S.C. Gordon I. Jacobson Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients J Hepatol 41 2004 935 942
121. A. Zaman H.R. Rosen K. Ingram Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients Am J Med 120 2007 280
122. C. Christensen D. Bruden S. Livingston Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients J Viral Hepat 13 2006 652 658
123. W.M. Rosenberg M. Voelker R. Thiel Serum markers detect the presence of liver fibrosis: a cohort study Gastroenterology 127 2004 1704 1713
124. N. Callewaert H. Van Vlierberghe A. Van Hecke Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics Nat Med 10 2004 429 434
125. H. Honda H. Onitsuka K. Masuda Chronic liver disease: value of volumetry of liver and spleen with computed tomography Radiat Med 8 1990 222 226
126. C.F. Hess U. Schmiedl G. Koelbel Diagnosis of liver cirrhosis with US: receiver-operating characteristic analysis of multidimensional caudate lobe indexes Radiology 171 1989 349 351
127. S. Gaiani L. Gramantieri N. Venturoli What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy J Hepatol 27 1997 979 985
128. C. Aube F. Oberti N. Korali Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis J Hepatol 30 1999 472 478
129. L. Sandrin M. Tanter J.L. Gennisson Shear elasticity probe for soft tissues with 1-D transient elastography IEEE Trans Ultrason Ferroelectr Freq Control 49 2002 436 446
130. L. Sandrin B. Fourquet J.M. Hasquenoph Transient elastography: a new noninvasive method for assessment of hepatic fibrosis Ultrasound Med Biol 29 2003 1705 1713
131. A. Kettaneh P. Marcellin C. Douvin Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients J Hepatol 46 2007 628 634
132. W.C. Yeh P.C. Li Y.M. Jeng Elastic modulus measurements of human liver and correlation with pathology Ultrasound Med Biol 28 2002 467 474
133. J.A. Talwalkar D.M. Kurtz S.J. Schoenleber Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis Clin Gastroenterol Hepatol 5 2007 1214 1220
134. A.A. Shaheen A.F. Wan R.P. Myers FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy Am J Gastroenterol 102 2007 2589 2600
135. L. Huwart C. Sempoux N. Salameh Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index Radiology 245 2007 458 466
136. M. Yin J.A. Talwalkar K.J. Glaser Assessment of hepatic fibrosis with magnetic resonance elastography Clin Gastroenterol Hepatol 5 2007 1207 1213
137. R. Malik N. Afdhal Stiffness and impedance: the new liver biomarkers Clin Gastroenterol Hepatol 5 2007 1144 1146
138. K. Patel S.C. Gordon I. Jacobson Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients J Hepatol 41 2004 935 942